This hypothesis proposes that precise, neuron-specific TFEB modulation at optimal levels, combined with trehalose co-treatment, can restore lysosomal function in Alzheimer's disease while avoiding the detrimental effects of global TFEB activation. Building on the 'Goldilocks principle' that TFEB requires precise dosing to avoid toxicity, we will use neuron-specific promoters (such as CaMKII or synapsin) to drive moderate TFEB overexpression exclusively in excitatory neurons of AD-affected brain
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.75
Evidence
0.00
Novelty
0.00
Feasibility
0.00
Impact
0.00
Druggability
0.50
Safety
0.45
Competition
0.55
Data
0.60
Reproducible
0.55
KG Connect
0.54
Score Breakdown
Dimension
Cell-Type-Specific TFEB Modula
Mechanistic
0.750
Evidence
0.000
Novelty
0.000
Feasibility
0.000
Impact
0.000
Druggability
0.500
Safety
0.450
Competition
0.550
Data
0.600
Reproducible
0.550
KG Connect
0.540
Evidence
Cell-Type-Specific TFEB Modulation Combined with Trehalose f
No evidence citations yet
Debate Excerpts
Cell-Type-Specific TFEB Modulation Combined with T
4 rounds · quality: 0.50
Persona-Theorist
# Therapeutic Hypotheses: Synaptic Protein Turnover in Aging & Neurodegeneration
---
## Hypothesis 1: TFEB Activation to Restore Lysosomal Biogenesis in Aged Synapses
**Title:** Small-molecule TF...
Persona-Skeptic
# Critical Evaluation of Synaptic Proteostasis Therapeutic Hypotheses
## Hypothesis 1: TFEB Activation to Restore Lysosomal Biogenesis
### Weaknesses in Evidence
**1. Pleiotropic transcriptional ...
Persona-Domain Expert
# Drug Development Feasibility Analysis: Synaptic Proteostasis Hypotheses
## Executive Summary
All seven hypotheses target mechanistically plausible nodes in synaptic proteostasis, but face signif...